Maire A Conrad, MD, MS
Assistant Professor of Pediatrics (Gastroenterology, Hepatology and Nutrition) at the Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of Gastroenterology, Hepatology and Nutrition
3401 Civic Center Boulevard
Philadelphia, PA 19104
Division of Gastroenterology, Hepatology and Nutrition
3401 Civic Center Boulevard
Philadelphia, PA 19104
Office: 267-426-1495
Fax: 215-590-3606
Fax: 215-590-3606
Publications
Education:
BS (Biology)
The College of New Jersey, 2003.
MS (Human Nutrition)
Columbia University College of Physicians and Surgeons, 2004.
MD
Drexel University College of Medicine, 2010.
MS (Translational Research)
University of Pennsylvania School of Medicine, 2021.
Permanent linkBS (Biology)
The College of New Jersey, 2003.
MS (Human Nutrition)
Columbia University College of Physicians and Surgeons, 2004.
MD
Drexel University College of Medicine, 2010.
MS (Translational Research)
University of Pennsylvania School of Medicine, 2021.
Description of Clinical Expertise
pediatric inflammatory bowel disease, very early onset inflammatory bowel diseaseDescription of Research Expertise
pediatric inflammatory bowel disease, very early onset inflammatory bowel disease, translational microbiome studies, host-microbe interactionsSelected Publications
Conrad MA, Bittinger K, Ren Y, Kachelries K, Vales J, Li H, Wu GD, Bushman FD, Devoto M, Baldassano RN, Kelsen JR. : The intestinal microbiome of inflammatory bowel disease across the pediatric age range Gut Microbes 16(1), Jan 2024.Lemons JMS*, Conrad MA*, Tanes C, Chen J, Friedman ES, Roggiani M, Curry D, Chau L, Hecht AL, Harling L, Vales J, Kacherlies KE, Baldassano RN, Goulian M, Bittinger K, Master SR, Lu L, Wu GD: Enterobacteriaceae growth promotion by intestinal acylcarnitines, a biomarker of dysbiosis in Inflammatory Bowel Disease. Cellular and Molecular Gastroenterology and Hepatology 17: 131-148, September 2023.
Conrad MA, Wu G, Kelsen JR: Chapter 4: The Gut Microbiota and Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease. Springer, 4: 49-59, 2023.
Nema, N, Dawany N, Constant B, Albenberg L, Stein R, Mitchel E, Patel T, Boyer B, Grossman A, Baldassano R, Kelsen J, Conrad M: Upadacitinib for the treatment of refractory pediatric inflammatory bowel disease. Gastroenterology 2023 Notes: oral presentation at Digestive Disease Week 2023.
Gonzalez I, Conrad MA, Weinbrom S, Patel T, Kelsen JR, Russo P,: Clinicopathologic Characterization of Lymphocytic Colitis in the Pediatric Population. Pediatric and Developmental Pathology 2023 Notes: In press.
Shaul E, Conrad MA, Dawany N, Patel T, Canavan MC, Baccarella A, Weinbrom S, Aleynick D, Sullivan KE, Kelsen JR.: Canakinumab for the treatment of autoinflammatory very early onset- inflammatory bowel disease. Front Immunol 13, September 2022.
Wilkins BJ, Kelsen JR, Conrad MA: Reply to: A Pattern-based Approach and Multidisciplinary Discussion Are Fundamental for Diagnosis in Very Early Onset Inflammatory Bowel Disease (VEO-IBD). Adv Anat Pathol 29(4): 260, July 2022.
Kelsen J, Dawany N, Conrad M, Patel T, Devoto M, Maurer K, Sullivan KE. : Clinical and laboratory predictors of monogenic very early onset inflammatory bowel disease. Clin Immunol. Jul 2022.
Rudra S, Shaul E, Conrad M, Patel T, Moore A, Dawany N, Canavan MC, Sullivan KE, Behrens E, Kelsen J.: Ruxolitinib: Targeted Approach for Treatment of Autoinflammatory Very Early Onset Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 20(6): 1408-10, June 2022.
Wilkins BJ, Kelsen JR, Conrad MA: A pattern-based pathology approach to very early onset inflammatory bowel disease: thinking beyond crohn disease and ulcerative colitis. Adv Anat Pathol 29(1): 62-70, Jan 2022.